Detection of boldenone in the urine of female horses—ex vivo formation versus administration

Abstract

AbstractBoldenone is an anabolic–androgenic steroid (AAS) that is prohibited in equine sports. However, in certain situations, it is endogenous, potentially formed by the microbes in urine. An approach to the differentiation based on the detection of the biomarkers Δ1‐progesterone, 20(S)‐hydroxy‐Δ1‐progesterone and 20(S)‐hydroxyprogesterone was assessed, and their concentrations were monitored in the urine of untreated female horses (n = 291) alongside boldenone, boldienone, testosterone and androstenedione. Using an ultra‐sensitive analytical method, boldenone (256 ± 236 pg/mL, n = 290) and the biomarkers (Δ1‐progesterone up to 57.6 pg/mL, n = 8; 20(S)‐hydroxy‐Δ1‐progesterone 85.3 ± 181 pg/mL, n = 130; 20(S)‐hydroxyprogesterone 43.5 ± 92.1 pg/mL, n = 158) were detected at low concentrations. The ex vivo production of Δ1‐steroids was artificially induced following the storage of urine samples at room temperature for 7 days in order to assess the concentrations and ratios of the monitored steroids. The administration of inappropriately stored feed source also resulted in an increase in 20(S)‐hydroxy‐Δ1‐progesterone concentrations and the biomarker ratios. Using the results from different datasets, an approach to differentiation was developed. In situations where the presence of boldenone exceeds a proposed action limit of 5 ng/mL, the presence of the biomarkers would be investigated. If Δ1‐progesterone is above 50 pg/mL or if 20(S)‐hydroxy‐Δ1‐progesterone is above 100 pg/mL with the ratio of 20(S)‐hydroxy‐Δ1‐progesterone:20(S)‐hydroxyprogesterone greater than 5:1, then this would indicate ex vivo transformation or consumption of altered feed rather than steroid administration. There remains a (small) possibility of a false negative result, but the model increases confidence that adverse analytical findings reported in female horses are caused by AAS administrations.